Mersana Therapeutics, Inc. (MRSN)
NASDAQ: MRSN · Real-Time Price · USD
0.550
-0.069 (-11.11%)
At close: Jan 21, 2025, 4:00 PM
0.570
+0.020 (3.66%)
After-hours: Jan 21, 2025, 7:56 PM EST
Mersana Therapeutics Employees
Mersana Therapeutics had 123 employees as of December 31, 2023. The number of employees decreased by 105 or -46.05% compared to the previous year.
Employees
123
Change (1Y)
-105
Growth (1Y)
-46.05%
Revenue / Employee
$283,228
Profits / Employee
-$606,659
Market Cap
67.93M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
MRSN News
- 11 days ago - Why Is Cancer-Focused Mersana Therapeutics Stock Trading Lower On Friday? - Benzinga
- 11 days ago - Mersana Therapeutics Announces Additional FDA Fast Track Designation Granted to Emiltatug Ledadotin (XMT-1660) - GlobeNewsWire
- 11 days ago - Mersana Therapeutics Announces Positive Initial Clinical Data from Phase 1 Clinical Trial of Emiltatug Ledadotin (XMT-1660); Initiation of Expansion in Triple Negative Breast Cancer - GlobeNewsWire
- 4 weeks ago - Mersana Therapeutics: We're About To Find Out If ADC Platform Is More Tolerable - Seeking Alpha
- 2 months ago - Mersana Therapeutics, Inc. (MRSN) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Mersana Therapeutics Provides Business Update and Announces Third Quarter 2024 Financial Results - GlobeNewsWire
- 2 months ago - Mersana Therapeutics to Host Third Quarter 2024 Conference Call on November 13, 2024 - GlobeNewsWire
- 5 months ago - Mersana Therapeutics, Inc. (MRSN) Q2 2024 Earnings Call Transcript - Seeking Alpha